
Kamal Kumar Ray
About Kamal Kumar Ray
Data last updated:
Kamal Kumar Ray is a Director at Cts Clinical Trial Services India Private Limited (since 2018) and Director at Mydoux Technologies Private Limited (since 2018). The companies operate in Healthcare and Information Technology. The 2 current companies with reported revenue have a combined latest revenue of ₹64.3 Lakh; the largest is Cts Clinical Trial Services India Private Limited at ₹62 Lakh (FY 2017).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 03 Sep 2018 | 2015 | ₹62 Lakh (FY 2017) | Active | |
| Director | 03 Sep 2018 | 2014 | ₹2.3 Lakh (FY 2017) | Active |
Board colleagues of Kamal Kumar Ray
| Name | DIN | Company | Designation |
|---|---|---|---|
| Devesh Kumar | 06762164 | Cts Clinical Trial Services India Private Limited , Mydoux Technologies Private Limited | Managing Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Kamal Kumar Ray
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kamal Kumar Ray
Kamal Kumar Ray currently holds 2 directorships: Cts Clinical Trial Services India Private Limited (Director, since 03 Sep 2018, revenue ₹62 Lakh (FY 2017)); Mydoux Technologies Private Limited (Director, since 03 Sep 2018, revenue ₹2.3 Lakh (FY 2017)).
Kamal Kumar Ray was first appointed on 03 Sep 2018 as Director at Cts Clinical Trial Services India Private Limited.
The 2 current companies of Kamal Kumar Ray that report revenue have a combined latest revenue of ₹64.3 Lakh: Cts Clinical Trial Services India Private Limited ₹62 Lakh (FY 2017); Mydoux Technologies Private Limited ₹2.3 Lakh (FY 2017).
The current boards of Kamal Kumar Ray's companies include Devesh Kumar (Cts Clinical Trial Services India Private Limited).